NFKB1 and Cachexia: Although our results showed that cachectic symptoms were relieved and NF-κB along with AMPK-HSL pathway were influenced by CSO administration, without backward verification using exogenous pathway activator, we still cannot sufficiently conclude the anti-cachexia effects of CSO are mediated by NF-κB and AMPK-HSL pathway.